Randomized, multicenter study comparing the immediate adjuvant radiotherapy associate with hormonal therapy of LH-RH analogue (Decapeptyl LP) vs delayed radiotherapy until biochemical relapse associated with hormonal therapy of LH-RH analogue (Decapeptyl LP) in patients with operable prostate cancer pT3 R1 pN0 or pNx at intermediate risk.
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 25 May 2018
At a glance
- Drugs Triptorelin (Primary)
- Indications Prostate cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 06 May 2018 Planned primary completion date changed from 1 Dec 2022 to 1 Apr 2022.
- 06 May 2018 Status changed from recruiting to active, no longer recruiting.